Search For "covax"
Private hospitals can't directly procure COVID vaccines, need to place ord
Updated : 4 years, 9 months ago IST
New Delhi [India], June 30 (ANI): Starting July 1, private hospitals in the country will no longer be allowed to directly procure COVID-19 vaccines from manufacturers and have to place orders on the Centre's CoWIN portal.
Read More
Covaxin effectively neutralises both Alpha, Delta variants of Covid-19: US
Updated : 4 years, 9 months ago IST
Washington DC [US], June 30 (ANI): The National Institute of Health (NIH) in the United States has found that Bharat Biotech's COVAXIN vaccine generates antibodies that effectively neutralize both Alpha and Delta variants of COVID-19.
Read More
Brazil to suspend Covaxin vaccine deal
Updated : 4 years, 9 months ago IST
Brasilia [Brazil], June 30 (ANI): Amid a probe into accusations of irregularities against President Jair Bolsonaro, Brazil's health minister has announced that the country will suspend a USD 324 million contract to buy 20 million doses of Bharat Biotech's Covaxin.
Read More
Patna Hospital places order for nearly 3000 doses of Sputnik V,Director sa
Updated : 4 years, 9 months ago IST
Patna (Bihar) [India], June 28 (ANI): Stating that Russian COVID-19 vaccine 'Sputnik V' is over 90 per cent effective and other vaccines including Covishield and Covaxin are already available for free at government hospitals, Arun Kumar, Medical Director of Jay Prabha Medanta Hospital, Patna
Read More
Mamata Banerjee urges PM Modi's intervention for early approval for Covaxi
Updated : 4 years, 9 months ago IST
Kolkata (West Bengal) [India], June 24 (ANI): West Bengal Chief Minister Mamata Banerjee on Thursday urged Prime Minister Modi for his intervention in order to receive early approval for indigenous COVID-19 vaccine, 'Covaxin' from the World Health Organization (WHO).
Read More
ICMR, NIV to study if vaccines in India can neutralise Delta Plus variant
Updated : 4 years, 9 months ago IST
New Delhi [India], June 23 (ANI): Following the detection of 'Delta Plus' variant in COVID patients in some parts of the country, the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV) have decided to conduct a study to see if the new and more potent va
Read More
DCGI likely to approve phase 3 trial data of Covaxin on Tuesday
Updated : 4 years, 9 months ago IST
New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin on Tuesday, sources said.
Read More
Bharat Biotech's Covaxin shows 77.8 pc efficacy in Phase III trials, say s
Updated : 4 years, 9 months ago IST
New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources.
Read More
DCGI's expert panel to review Phase III data of Covaxin today
Updated : 4 years, 9 months ago IST
New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss reviewing the Phase III data of Bharat Biotech's Covaxin on Tuesday.
Read More
Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt
Updated : 4 years, 9 months ago IST
New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources.
Read More
India to favour discussions on 'vaccine passports' with greater focus on v
Updated : 4 years, 9 months ago IST
New Delhi [India], June 17 (ANI): While countries like Japan deciding to issue "vaccine passports" as proof of immunisation for its citizens travelling abroad, India on Thursday said that it will favour discussion with a greater focus on vaccine equity, since many developing nations are y
Read More
Bharat Biotech, WHO pre-submission meeting on June 23: WHO
Updated : 4 years, 9 months ago IST
New Delhi [India], June 17 (ANI): Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use Listing (EUL) of its indigenous COVID-19 vaccine Covaxin.
Read More